Overview of the risk factors, prevention and management of SARS-COV-2
This thesis report is submitted in partial fulfillment of the requirement for the degree of Master of Science in Biotechnology, 2020.
Päätekijä: | Mustafa, Nashrah |
---|---|
Muut tekijät: | Hossain, Mahboob |
Aineistotyyppi: | Opinnäyte |
Kieli: | en_US |
Julkaistu: |
Brac University
2021
|
Aiheet: | |
Linkit: | http://hdl.handle.net/10361/14501 |
Samankaltaisia teoksia
-
In-silico based vaccine development: targeting nucleocapsid protein of SARS-CoV-2.
Tekijä: Iva, Yesmine Akter
Julkaistu: (2022) -
Detection of genetic diversity of SARS-CoV-2 in wastewater to monitor COVID-19 transmission
Tekijä: Sarwar, Subyeta Binte
Julkaistu: (2024) -
An in silico Method to developing an epitope-based peptide vaccination against SARS-CoV-2's Envelope Protein (E)
Tekijä: Intesar, Mohammad Nafees
Julkaistu: (2023) -
Omicron, delta, and beta, deadliest among SARS-CoV-2 variants: an in silico analysis
Tekijä: Bosu, Sagar
Julkaistu: (2023) -
Wave-wise comparison of COVID 19 based on SARS-CoV-2 Variants of Concern (VOCs) in Bangladesh, India, Sri Lanka, Pakistan, Nepal and the probable reasons behind the less devastating effects of Delta variant in Bangladesh: a review
Tekijä: Hasan, Mahfuzul, et al.
Julkaistu: (2022)